New hope for dangerous blood sugar drops after gastric bypass
NCT ID NCT06747468
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study tests a drug called avexitide in 75 adults who have severe low blood sugar episodes after gastric bypass surgery. The goal is to see if the drug can reduce these dangerous events compared to a placebo. Participants will be monitored for 16 weeks, with an option to continue in an open-label extension for about 32 more weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-BARIATRIC HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Centricity Research Morehead City Multispecialty
Morehead City, North Carolina, 28557-3126, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195-0001, United States
-
Consano Clinical Research
Shavano Park, Texas, 78231-1281, United States
-
Cotton-O'Neil Diabetes and Endocrinology Center
Topeka, Kansas, 66606-2806, United States
-
Diabetes and Gandular Disease Clinic
San Antonio, Texas, 78229-4801, United States
-
Duke Center for Metabolic and Weight Loss Surgery
Durham, North Carolina, 27704-2726, United States
-
East Coast Institute for Research
Jacksonville, Florida, 32216, United States
-
Endocrine and Psychiatry Center
Houston, Texas, 77095-2856, United States
-
Georgia Clincal Research
Lawrenceville, Georgia, 30044, United States
-
Hanson Diabetes Center
Port Charlotte, Florida, 33952-6722, United States
-
Joslin Diabetes Center
Boston, Massachusetts, 02215-5306, United States
-
NYC Health + Hospitals/Queens - BRANY
New Hyde Park, New York, 11042-1214, United States
-
Penn Medicine University City
Philadelphia, Pennsylvania, 19104, United States
-
Southern Endocrinology & Diabetes Associates
Mesquite, Texas, 75149, United States
-
Stanford Health Care - Endocrinology Clinic
Stanford, California, 94304, United States
-
Texas Valley Clinical Research, LLC
Weslaco, Texas, 78596-7288, United States
-
UT Health San Antonio
San Antonio, Texas, 78229-3931, United States
-
UWHealth - Junction Rd Medical Center Endocrinology Clinic
Madison, Wisconsin, 53717-2656, United States
-
University of Colorado Health Anschutz Medical Campus
Aurora, Colorado, 80045-2541, United States
-
Vanderbilt Weight Loss Center
Nashville, Tennessee, 37212-3609, United States
Conditions
Explore the condition pages connected to this study.